Delivery Order SPE2DB24D3014-SPE2DB25FKTQJ
Award Date 6/4/25
Potential Completion Date 6/26/25
Potential Value $3.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,687.48 to AmerisourceBergen Drug Corp for PROQUAD vials, with an ultimate completion date of July 22, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. PROQUAD is a combination vaccine used to prevent measles, mumps, rubella, and varicella, representing part of the...
- The Defense Logistics Agency awarded a $6,617.32 delivery order to AmerisourceBergen Drug Corp for PROQUAD vials under a firm fixed-price contract type. The award was made on September 10, 2025, with an ultimate completion date of October 1, 2025. This is an unset-aside, competitively awarded delivery order performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. PROQUAD is a combination vaccine used for immunization against measles, mumps, rubella, and varicella,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,683.64 to AmerisourceBergen Drug Corp for PROQUAD vials, with a completion deadline of November 28, 2025. This firm fixed-price delivery order, issued on November 5, 2025, represents a non-set-aside competitive award to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. PROQUAD is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, indicating this contract...
- The Defense Logistics Agency awarded a delivery order valued at $9,274.48 to AmerisourceBergen Drug Corp for PROQUAD vials, with an ultimate completion date of September 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed competitively. The contract specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. PROQUAD is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, representing the...
- The Defense Logistics Agency awarded a delivery order valued at $3,374.96 to AmerisourceBergen Drug Corp on May 12, 2025, for PROQUAD vials, with a completion date of June 3, 2025. This non-set-aside, firm fixed-price delivery order will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems, with...
- The Defense Logistics Agency awarded a delivery order valued at $3,341.80 to AmerisourceBergen Drug Corp for ProQuad vials on August 15, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used to immunize against measles, mumps, rubella, and varicella, representing...
- The Defense Logistics Agency awarded a $5,062.32 delivery order to AmerisourceBergen Drug Corp for ProQuad vials under a firm fixed-price contract. The delivery order, which has an ultimate completion date of August 21, 2025, was awarded on July 31, 2025, with no set-aside designation. Performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine product, and this delivery order represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,687.48 to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The contract specifies performance at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $2,740.40 with an ultimate completion date of August 19, 2025. This firm fixed price, competitively awarded delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $16,543.30 delivery order to AmerisourceBergen Drug Corp for ProQuad vials, a combination vaccine product, with a completion date of August 21, 2025. This competitive award (no set-aside used) was issued under a firm fixed-price structure and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...